Sfoglia per Autore
Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors
2004 F. Facchetti, S. Previdi, M. Ballarini, S. Minucci, P. Perego, C. La Porta
Identification of stem cell like population in human melanoma
2005 C.A.M. La Porta, F. Facchetti, G. Inverici, E. Corsini, A. Benetti, E. Monzani, C. Cavazzini, A. Gritti, E. Galmozzi, M. Santinami, E. Parati, G. Alessandri
BRAF V599E mutation occurs in Spitz and Reed nevi
2006 C. La Porta, R. Cardani, F. Facchetti, P. Presicce, S. Rao, E. Privitera, C. Clemente, M. C. Mihm
Cancer stem cells and therapeutic perspectives
2006 E. Galmozzi, F. Facchetti, C.A.M. La Porta
Unique expression and localization of aquaporin- 4 and aquaporin-9 in murine and human neural stem cells and in their glial progeny
2006 C. Cavazzin, D. Ferrari, F. Facchetti, A. Russignan, A.L. Vescovi, C. La Porta, A. Gritti
New perspectives in the treatment of melanoma : anti-angiogenic and anti-lymphoangiogenic strategies
2007 F. Facchetti, E. Monzani, C.A.M. La Porta
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumorigenic potential
2007 E. Monzani, F. Facchetti, E. Galmozzi, E. Corsini, A. Benetti, C. Cavazzin, A. Gritti, A.A. Piccinini, D. Porro, M. Santinami, G. Invernici, E. Parati, G. Alessandri, C. La Porta
CD133 positive cellular population in human melanoma
2007 C. Anna Maria la Porta, E. Monzani, F. Facchetti, E. Galmozzi, E. Corsini, A. Benetti, C. Cavazzin, A. Gritti, A.A.M. Piccinini, M. Santinami, E. Parati, G. Alessandri
CD133 postive cellular population in human melanoma
2007 C. La Porta, E. Monzani, E. Corsini, F. Facchetti, E. Galmozzi, A. Benetti, C. Cavazzin, A. Gritti, A.A. Piccinini, M. Santinami, E. Parati, G. Alessandri
Effect of a caloric restriction regimen on the angiogenic capacity of aorta and on the expression of endothelin-1 during ageing
2007 F. Facchetti, E. Monzani, G. Cavallini, E. Bergamini, C.A.M. La Porta
Effectiveness of Entecavir for the treatment of NUC-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice
2008 P. Lampertico, M. Viganò, F. Facchetti, M. Puoti, E. Minola, F. Suter, M. Brunetto, B. Coco, S. Fargion, E. Fatta, P. Del Poggio, M. Pozzi, M. Milanese, G. Colloredo, S. Fagiuoli, L. Pasulo, M. Colombo
Failure of adefovir 20 mg to improve suboptimal response in lamivudine resistant hepatitis B patients treated with adefovir 10 mg and lamivudine
2008 M. Viganò, P. Lampertico, F. Facchetti, G. Lunghi, M. Colombo
Knockdown of AQP1 in HMEC-1 cells and WM115 cells changes the organisation of the cytoskeleton
2008 C. La Porta, E. Monzani, F. Facchetti, C. Perego
High risk of renal impairment and arterial hypertension during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B
2008 M. Viganò, P. Lampertico, M. Iavarone, G.E. Tontini, F. Facchetti, M. Colombo
Four years of Adefovir add-on in 145 lamivudine resistant patients with chronic hepatitis B : low risk of genotypic resistance to ADV and prevention of virologic breakthrough
2008 P. Lampertico, M. Viganò, F. Facchetti, M. Iavarone, M. Colombo
Entecavir for nuc-naïve chronic hepatitis B patients in clinical practice : long-term effectiveness from a large multicenter cohort study in 376 patients
2009 P. Lampertico, M. Viganò, F. Facchetti, F. Suter, E. Minola, O. Fracassetti, G. Carosi, M. Puoti, G. Rizzardini, G. Gubertini, C. Magni, G. Antonucci, A. Testa, P. Del Poggio, S. Fargion, E. Fatta, M.R. Brunetto, B. Coco, A. Colli, M. Andreoletti, T.A. Santantonio, M. Fasano, G. Colloredo, L. Pasulo, M. Milanese, N. Terreni, M. Borzio, G. Lunghi, R. Soffredini, M. Colombo
Lamivudine prophylaxis of hepatitis B reactivation in anti-HBC seroposivive patients undergoing chemotherapy for onco-hematological diseases
2009 M. Viganò, B. Olivero, P. Lampertico, D. Vincenti, M.C. Goldaniga, F. Facchetti, L. Baldini, A. Cortelezzi, G. Lambertenghi Deliliers, M. Colombo
High risk of renal impairment during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B
2009 M. Viganò, P. Lampertico, M. Iavarone, G.E. Tontini, F. Facchetti, M. Colombo
Effectiveness of entecavir for the treatment of NUC-naïve chronic hepatitis B patients : A large multicenter cohort study in clinical practice
2009 P. Lampertico, M. Viganò, F. Facchetti, E. Minola, F. Suter, M. Puoti, M. Brunetto, B. Coco, S.R. Fargion, E. Fatta, P. Del Poggio, M. Pozzi, M. Milanese, G. Colloredo, S. Fagiuoli, L. Pasulo, M.A. Iavarone, M. Colombo
High risk of renal impairment during long-term adefovir and lamivudine combination therapy in patients with lamivudine-resistant chronic hepatitis B
2009 M. Viganò, P. Lampertico, M. Iavarone, G.E. Tontini, F. Facchetti, M.G. Colombo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile